People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of information on seven main topic areas (incidence, chronicity, genotypes, HIV co-infection, diagnosis and treatment uptake, and burden of disease) to guide HCV treatment and prevention scale-up for PWID in the 27 countries of the European Union is systematically reviewed.status: publishe
BACKGROUND: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
Hepatitis C among drug users in Europe: epidemiology, treatment and prevention provides a timely con...
Purpose of review The burden of hepatitis C virus (HCV) is high among people who inject drugs (PWID)...
People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment o...
People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment o...
BACKGROUND:People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). ...
Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
<div><p>Background</p><p>People who inject drugs (PWID) are a key population affected by hepatitis C...
Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HC...
Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
BACKGROUND: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
BACKGROUND: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
Background Fifteen million adults in the World Health Organization European Region are estimated to...
BACKGROUND: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
BACKGROUND: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
Hepatitis C among drug users in Europe: epidemiology, treatment and prevention provides a timely con...
Purpose of review The burden of hepatitis C virus (HCV) is high among people who inject drugs (PWID)...
People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment o...
People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment o...
BACKGROUND:People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). ...
Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
<div><p>Background</p><p>People who inject drugs (PWID) are a key population affected by hepatitis C...
Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HC...
Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
BACKGROUND: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
BACKGROUND: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
Background Fifteen million adults in the World Health Organization European Region are estimated to...
BACKGROUND: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
BACKGROUND: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV)....
Hepatitis C among drug users in Europe: epidemiology, treatment and prevention provides a timely con...
Purpose of review The burden of hepatitis C virus (HCV) is high among people who inject drugs (PWID)...